Product Information
LURASIDONE HCL 60 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.4298 per EA under NDC 16729034810. Its NADAC has been published 83 times since Apr 19, 2023.
FDA first approved this application on Jan 3, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the lurasidone hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
60 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729034810
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
10/23/2024
Active Ingredients
LURASIDONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208049FDA Approved
1/3/2019
TE Code
AB
On Market Since
2/20/2023
Pharmacological Classes
Price Statistics
The NADAC for LURASIDONE HCL 60 MG TABLET has been published 83 times since Apr 19, 2023, and over the history we have for it it has declined 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4298 per EA |
|---|---|
| All-time high | $0.4949 (Jul 12, 2023) |
| All-time low | $0.3665 (Jul 17, 2024) |
| Median price | $0.4333 |
| Average price | $0.4339 |
| Largest weekly change | +23.2% (Aug 21, 2024) |
| Weeks tracked | 83 |
| Tracking since | Apr 19, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-0.8%
5Y
N/A
All
-9.7%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LURASIDONE HCL 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LURASIDONE HCL 60 MG TABLET, manufactured by Accord Healthcare Inc., is $0.4298 per EA (NDC 16729034810), effective Nov 13, 2024.
How has the price of LURASIDONE HCL 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for LURASIDONE HCL 60 MG TABLET has declined 9.7%. It has been tracked across 83 weekly CMS publications since Apr 19, 2023.
What are the highest and lowest recorded NADAC prices for LURASIDONE HCL 60 MG TABLET?
Since Apr 19, 2023, the NADAC for LURASIDONE HCL 60 MG TABLET has ranged from a low of $0.3665 (Jul 17, 2024) to a high of $0.4949 (Jul 12, 2023), with a median of $0.4333 per EA.
Are there cheaper alternatives to LURASIDONE HCL 60 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LURASIDONE HCL 60 MG TABLET, is $0.2860 per EA — about 33% below LURASIDONE HCL 60 MG TABLET.
Who manufactures LURASIDONE HCL 60 MG TABLET?
LURASIDONE HCL 60 MG TABLET (NDC 16729034810) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.